Skip to main content

Table 2 Cox proportional hazard regression analysis of recurrence-free survival in patients diagnosed with stage IA micropapillary non-predominant lung adenocarcinoma with a micropapillary component > 5%

From: Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components

Variables

Univariate Analysis

Multivariate Analysis

HR

95% CI

P value

HR

95% CI

P value

Age

0.992

0.950–1.036

0.727

   

Sex

 Female

Ref

  

Ref

  

 Male

0.340

0.133–0.871

0.025

0.441

0.146–1.332

0.146

Smoking history

 Non-smoker

Ref

     

 Smoker

0.876

0.323–2.376

0.795

   

Surgical procedure

 Open

Ref

     

 VATS

0.616

0.227–1.671

0.341

   

Resection range

 Sublobar resection

Ref

  

Ref

  

 Lobectomy

0.346

0.141–0.850

0.021

0.071

0.020–0.251

 < 0.001

Surgical side

 Left

Ref

     

 Right

1.067

0.456–2.498

0.881

   

Number of LN dissected

1.007

0.951–1.067

0.804

   

Tumor size

2.214

1.073–4.570

0.032

2.929

1.171–7.330

0.022

Micropapillary component

1.034

0.988–1.083

0.152

   

Papillary component

1.002

0.989–1.016

0.760

   

Solid component

0.987

0.957–1.019

0.432

   

Acinar component

0.995

0.982–1.007

0.397

   

Lepidic component

1.005

0.992–1.019

0.442

   

Lymphovascular invasion

 No

Ref

     

 Yes

0.581

0.078–4.329

0.597

   

Spread through air spaces

 No

Ref

     

 Yes

0.837

0.247–2.837

0.775

   

pTNM stage

 IA1

Ref

     

 IA2

6990.189

0–6.386E + 80

0.922

   

 IA3

12,719.830

0–1.162E + 81

0.917

   

Adjuvant chemotherapy

 No

Ref

  

Ref

  

 Yes

0.325

0.127–0.832

0.019

0.122

0.037–0.403

0.001

  1. VATS Video-assisted thoracoscopic surgery, LN Lymph node, pTNM Pathological tumor-node-metastasis, HR Hazard Ratio, CI Confidence interval, Ref Reference